Supreme Court

360 Stories, most recent news story added Tue Nov 17, 8:27 pm ET

US Supreme Court Appears Skeptical Of Merck In Vioxx Case

Nasdaq - Mon Nov 30, 1:47 pm ET

WASHINGTON -(Dow Jones)- The U.S. Supreme Court voiced skepticism Monday of Merck & Co. Inc.'s (MRK) arguments that shareholders waited too long to file securities lawsuits alleging the drug maker misrepresented the safety of painkiller drug Vioxx, which it removed from the market in 2004.

Cornell University: Supreme Court Decisions